HOME > TOP STORIES
TOP STORIES
-
BUSINESS Amgen Confident of Getting Handsome Slice of Japan Biosimilar Market: Exec
August 19, 2016
-
INTERVIEW Interview: Ex-Astellas Boss Takenaka Urges Mid-Size Makers to Be More Open to Academia in Pathological Research
August 18, 2016
-
REGULATORY AMED Taking Steps toward “Aggressive Intellectual Property Management”: IP Department Head
August 18, 2016
-
BUSINESS CEO of Teva-Takeda JV Confident on Handling Both Long-Listed Brands, Generics
August 17, 2016
-
BUSINESS Mitsubishi Tanabe to Focus on Sales Turnaround for Canaglu, Eyes Diabetes and Nephrology Sales of 100 Bil. Yen
August 17, 2016
-
REGULATORY MHLW OKs First Generics for Tracleer, 6 Other APIs towards December Listing
August 16, 2016
-
BUSINESS Teijin Gets Japan Rights to Versartis’ Growth Hormone Deficiency Treatment
August 15, 2016
-
REGULATORY MHLW Study Group to Look at Measures to Popularize Biosimilars, Increase Efficiency in Development and Manufacturing
August 12, 2016
-
REGULATORY Startup Promotion Guide to Support Major Companies as well: MHLW Official
August 10, 2016
-
REGULATORY JMA, MHLW Say Possible Opdivo Re-Pricing Is Emergency Step, Won’t Make It Slippery Slope to Annual Revisions
August 9, 2016
-
ORGANIZATION EFPIA Japan Calls for Relaxation of Japanese Vaccine Regulations: Vaccine Subcommittee Head
August 9, 2016
-
REGULATORY MHLW Panel OKs Opdivo for RCC, ASKA’s Hepatic Encephalopathy Drug
August 8, 2016
-
INTERVIEW Japan Biosimilar Association Aims to Share Knowledge and Experience to Popularize the Use of Biosimilars: Director General
August 5, 2016
-
REGULATORY Kipres/Singulair to Face Generic Onslaught in Dec.; Competition to Hit Tracleer, Too
August 4, 2016
-
ACADEMIA 3 Scientific Societies to Set Up HBOC Body to Build BRCA Gene Database
August 4, 2016
-
REGULATORY MHLW to Gauge Possible Deregulation of Plasma Export Restriction towards FY2018: Blood Division Chief
August 3, 2016
-
BUSINESS Japan Market Grows in April-June on Hep C Meds, Opdivo: IMS
August 2, 2016
-
BUSINESS Takeda to Revamp R&D Organization, Eyes Consolidated Research Sites in Japan, US
August 1, 2016
-
REGULATORY Pricy Meds Issue Takes a Step Forward with 2-Faceted Proposal
July 29, 2016
-
REGULATORY Chuikyo to Discuss Out-of-Cycle Re-Pricing for Opdivo, but JMA Turns Wary
July 28, 2016
ページ
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
